दवाओं की अंतःक्रिया
Elacestrant + Eslicarbazepine
गंभीरता: गंभीर
Elacestrant and Eslicarbazepine: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Elacestrant is a CYP3A4 substrate, and inducers reduce its exposure. Eslicarbazepine may therefore decrease its efficacy in breast cancer.
इस इंटरैक्शन का सरल भाषा में अर्थ
Elacestrant and Eslicarbazepine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Elacestrant belongs to Oncology; Eslicarbazepine belongs to Central Nervous System.
ऐसा क्यों होता है
CYP3A4 induction by eslicarbazepine increases elacestrant clearance.
क्या करें
Avoid combination where possible by using a non-inducing antiseizure drug; labeling advises avoiding strong and moderate CYP3A inducers.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Elacestrant और Eslicarbazepine की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Eslicarbazepine के अन्य इंटरैक्शन
Elacestrant के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Elacestrant with Eslicarbazepine?
MediHelp rates the interaction as major. Elacestrant and Eslicarbazepine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Elacestrant is a CYP3A4 substrate, and inducers reduce its exposure. Eslicarbazepine may therefore decrease its efficacy in breast cancer.
How serious is the interaction between Elacestrant and Eslicarbazepine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combination where possible by using a non-inducing antiseizure drug; labeling advises avoiding strong and moderate CYP3A inducers.
What other medicines interact with Eslicarbazepine?
MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
